Description
AirPhysio is a drug-free lung expansion physiotherapy decive. It uses an all-natural Oscillating Positive Expiratory Pressure process to create positive pressure and vibration in the lungs.
The positive pressure helps to expand the airways, helping to maximise lung capacity, which potentially helps to do the following:
Medical compliance is not just the legal requirements in healthcare; they are also the critical components to safe, quality patient care and is a focal goal here at AirPhysio. Due to the drastic increase in demand on an international level, achieving these certifications in our major export locations is a big step. After a 3 year-long process, a major goal was achieved – the approval of the US FDA. The FDA’s standpoint is to protect the public with particular scopes on safety and efficacy when approving a product. The importance of the AirPhysio device being approved by the FDA shows that it has undergone a rigorous quality system process and review in a nation with such a vast global influence. AirPhysio now having this improved credibility and rapport with the FDA assists with the companies endeavour for global awareness to help improve the lives of all those suffering from respiratory conditions including; Asthma, COPD, Emphysema, Bronchitis, Cystic Fibrosis and other conditions producing retained secretions. To also improve the everyday individual’s lung capacity and function our introduced sliding scale device range includes 4 devices ranging from children to athlete, everyone has an opportunity for naturally better breathing.
The positive pressure helps to expand the airways, helping to maximise lung capacity, which potentially helps to do the following:
- Increase O2 and CO2 gas transfer
- Increase Exercise Time
- Reduce Recovery Time
Medical compliance is not just the legal requirements in healthcare; they are also the critical components to safe, quality patient care and is a focal goal here at AirPhysio. Due to the drastic increase in demand on an international level, achieving these certifications in our major export locations is a big step. After a 3 year-long process, a major goal was achieved – the approval of the US FDA. The FDA’s standpoint is to protect the public with particular scopes on safety and efficacy when approving a product. The importance of the AirPhysio device being approved by the FDA shows that it has undergone a rigorous quality system process and review in a nation with such a vast global influence. AirPhysio now having this improved credibility and rapport with the FDA assists with the companies endeavour for global awareness to help improve the lives of all those suffering from respiratory conditions including; Asthma, COPD, Emphysema, Bronchitis, Cystic Fibrosis and other conditions producing retained secretions. To also improve the everyday individual’s lung capacity and function our introduced sliding scale device range includes 4 devices ranging from children to athlete, everyone has an opportunity for naturally better breathing.